Saira Ramasastry - Jun 2, 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
Jody Howe, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jun 2, 2022
Transactions value $
$0
Form type
4
Date filed
6/6/2022, 08:39 PM
Previous filing
May 25, 2022
Next filing
Jun 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +34K $0.00 34K Jun 2, 2022 Common Stock 34K $23.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (June 2, 2022).